Document Detail

Clinical grade production of mesenchymal stem cells.
MedLine Citation:
PMID:  18334718     Owner:  NLM     Status:  MEDLINE    
Mesenchymal Stem Cells (MSCs) are multipotent adult stem cells having an immunosuppressive effect. These characteristics lead to an increasing use of MSC in graft process or for regenerative medicine. For the clinical uses of MSCs, standards are needed. The clinical grade production necessitates adhering to good manufacturing practices (GMP) to insure the delivery of a "cell drug" that is safe, reproducible and efficient. All parts of the process must be defined: the starting material (tissue origin, separation or enrichment procedures), cell density in culture, and medium (fetal calf serum (FCS) or human serum, cytokines with serum-free medium for target). But to reach the GMP goal, cells have to be cultured in as close to a closed system as possible. Analytical methods are needed to assay the active compound and impurities. At a minimum, quality control (QC) of cells must consider the phenotype, functional potential, microbiological safety, and ensure the cultured cells remain untransformed. Finally, quality assurance system (QA) procedures specific to the production of MSCs as a cell drug must be determined and implemented.
Luc Sensebé
Related Documents :
16982328 - A stro-1(+) human universal stromal feeder layer to expand/maintain human bone marrow h...
18300958 - Pretreatment of poly(l-lactide-co-glycolide) scaffolds with sodium hydroxide enhances o...
10586098 - Effect of osteoblastic culture conditions on the structure of poly(dl-lactic-co-glycoli...
16411808 - Analysis of the balance between proliferation and apoptosis of cultured vascular smooth...
14670098 - Fabrication and biocompatibility of collagen sponge reinforced with poly(glycolic acid)...
955628 - Biochemical characteristics of collagen produced by long term cultivated amniotic fluid...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Bio-medical materials and engineering     Volume:  18     ISSN:  0959-2989     ISO Abbreviation:  Biomed Mater Eng     Publication Date:  2008  
Date Detail:
Created Date:  2008-03-12     Completed Date:  2008-06-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9104021     Medline TA:  Biomed Mater Eng     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  S3-10     Citation Subset:  IM    
Etablissement français du sang (EFS), Centre-Atlantique and Inserm ESPRI-EA3855, Tours, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cell Culture Techniques / methods*,  standards*
Clinical Medicine / methods,  standards
Mesenchymal Stem Cell Transplantation / standards*
Mesenchymal Stem Cells / cytology*
Quality Assurance, Health Care / standards*
Tissue Engineering / methods*,  standards*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Comparing mesenchymal stromal cells from different human tissues: bone marrow, adipose tissue and um...
Next Document:  Cell therapy: a challenge in modern medicine.